focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 20th Mar 2023 15:54

Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Blackrock Throgmorton Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
LPA Group PLCAGM
Zaim Credit Systems PLCGM re director removal and name change to Adalan Ventures PLC
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
Quartix Technologies PLCAGM
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
Monday 27 March 
Let's Explore Group PLCGM re off-market purchase of the company's ordinary shares 
Oncimmune Holdings PLCGM re directors' remuneration
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Sep 2020 13:49

Oncimmune announces autoantibody profiling collaboration

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).

Read more
27 Jul 2020 18:11

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

Read more
27 Jul 2020 09:22

Roche extends scope and value of contract with Oncimmune

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.

Read more
2 Jul 2020 06:54

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

Read more
5 Jun 2020 14:10

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
4 Jun 2020 10:50

Oncimmune expects to report further strong top-line growth

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.

Read more
28 May 2020 15:32

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Read more
12 May 2020 16:42

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Read more
12 May 2020 15:32

Oncimmune signs collaboration deal with US biopharma company

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.

Read more
6 May 2020 14:57

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

Read more
5 May 2020 11:50

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

Read more
18 Mar 2020 18:09

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

Read more
18 Mar 2020 07:30

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

Read more
4 Mar 2020 12:57

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.